Table 2.
MicroRNAs associated with tumor cell extravasation across the blood–brain barrier and the formation of brain metastases
| microRNAs | Findings | Primary tumor | Refs |
|---|---|---|---|
| miR-509 | Highly expressed in primary tumors, while significantly downregulated in brain metastatic lesions. Regulates two genes: i) RhoC involved in MMP9 expression influencing cancer cell invasion and ii) TNF-α which modifies BBB permeability | Breast cancer | [132] |
| miR-7 | miR profile analysis of cancer stem-like cells revealed that significantly lower level of miR-7 was related to preferential organotropism for the brain, with reduced miR-7 producing greater levels of Kruppel-like factor 4 | [131] | |
| miR-105 | Identified in the circulation in pre-metastatic cancer patients, reflecting metastatic progression. Suppresses ZO-1, disrupting BBB integrity. Overexpression in non-metastatic tumor cells increases vascular permeability and brain metastases. Inhibition in highly brain metastatic cancer limits metastatic potential. Exosome-mediated miR-105 expression by brain metastatic breast cancer cells is associated with the reprograming of activated microglia, upregulating immune-suppressive cytokines and supporting metastatic niche formation | [78, 133] | |
| miR-19a | Astrocyte-derived exosomes containing miR-19a targeting PTEN in brain metastatic breast cancer cells, which activates the PI3K/Akt pathway, promoting invasion of the brain parenchyma | [134] | |
| miR-181c | Exome-delivered miR-181c facilitates disruption of the BBB in vitro and in vivo by downregulating the gene PDPK1, causing abnormal localization of actin | [79] | |
| miR-122 | Freely circulating miR-122 secreted by tumor cells downregulates the glycolytic enzyme pyruvate kinase, suppressing glucose uptake by astrocytes, in vitro and in vivo. Inhibition of miR-122 in vivo restored glucose uptake in the brain, reducing the incidence of metastasis | [81] | |
| miR-1290 and miR-1246 | High levels of tumor-secreted EV-mediated miR-1290 and miR-1246, activating astrocytes. Higher circulating EV levels in patients with metastases than without. MiR-1290- or miR-1246-overexpressing astrocytes promote mammospheres. Astrocytes overexpressing miR-1290, but not miR-1246, increase brain colonization and growth of tumor cells | [135] | |
| miR-378 | Overexpressed in both primary tumor and associated brain lesions compared to non-brain-metastasizing variants | Lung cancer | [137] |
| miR-328 and miR-330-3p | Expression pattern able to differentially predict patients positive and negative for brain metastases | [136] | |
| miR-142-3p | EV shuttling of long non-coding RNA LINC00482 to microglia induces microglial M2 polarization by binding to miR-142-3p and upregulating TGF-β1. This in turn facilitates pre-metastatic niche formation in vivo | [80] | |
| miR-150-5p, miR-15b-5p, miR-16-5p, and miR-374b-3p | Identified as a prognostic signature in a retrospective, cohort-based study analyzing genome-wide and targeted miR expression in primary melanoma tissue, improving predictions of brain metastases development | Melanoma | [138] |